The aim of this study was to investigate whether night work is related to breast cancer receptor status. The effect of night work on the risk of estrogen receptor-and progesterone receptor-defined breast cancers was evaluated in 513 nurses diagnosed with breast cancer between 1996 and 2007 and in 757 frequency-matched controls, all of whom were selected from a cohort of Norwegian nurses. Odds ratios for the exposure "duration of work with a minimum of 6 consecutive night shifts" were compared for tumor subgroups with respect to the common control group through the use of polytomous logistic regression. Statistically significant associations were observed between breast cancer and work durations of ≥5 years with ≥6 consecutive night shifts, with the highest risk observed for progesterone receptor-positive tumors (odds ratio = 2.4, 95% confidence interval: 1.3, 4.3; P-trend = 0.01). When the exposure variable was dichotomized (ever/never worked ≥6 consecutive night shifts), a borderline statistically significant heterogeneity (P = 0.05) was seen between progesterone receptor-positive and progesterone receptor-negative tumors in postmenopausal women. The association observed between consecutive night shifts and progesterone receptor-positive cancers suggests that progesterone could play an important role in the detrimental effects of night work.
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The impact of night work on breast cancer risk has been evaluated in many recent studies. In 2007, the International Agency for Research on Cancer categorized "shift-work that involves circadian disruption" as probably carcinogenic to humans (1) , and 9 of 13 published studies (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) on night work and breast cancer risk have indicated that night work represents a risk factor for breast cancer. In a previous study of Norwegian nurses, an association was found between breast cancer risk and night work, as characterized by a long duration of night work including several consecutive night shifts (12) , which suggests that the intensity of night work could be of particular importance. The original hypothesis of an association between night work and breast cancer, which was based on experiments with rodents, was that exposure to artificial light during the night causes suppression of the normal nocturnal rise in melatonin and might increase the levels of hormones such as estrogens (15) . Estrogen and progesterone are believed to play a central role in the development of breast cancer. Although the ensuing studies on night work and breast cancer have focused on improving the information on night work assessment, the particular breast cancer subgroups have not been adequately examined.
Several studies have suggested that the subgroups of breast cancer that are characterized by estrogen receptor (ER) and progesterone receptor (PR) status have different risk factors (16) (17) (18) . Indeed, the observation that the risk factors vary across hormone receptor subtypes would support the notion that breast cancer is a heterogeneous set of diseases with different genetic and environmental determinants. One of the questions raised in the present study is whether night work influences cancer risk through hormonal pathways. To our knowledge, only 1 previous epidemiologic study (3) has evaluated the association of night work with breast cancer subtypes related to hormone receptor status. In that study, a moderate increase of ER-positive (ER+) tumors was found with a longer duration of rotating shifts, particularly for premenopausal women.
In the present study, the relation between the exposure to night work and the risk of the specific breast cancer subtypes defined by ER and PR status was examined. The purpose was to improve our understanding of the mechanisms by which night work might alter breast cancer risk and to provide insight into possible etiological differences between hormone receptor-positive and hormone receptor-negative tumors.
MATERIALS AND METHODS

Cases and controls
The present study comprises an interview-based casecontrol study of women, 35-74 years of age, nested within an established cohort of 49,402 Norwegian nurses who graduated as nurses between 1914 and 1985. The breast cancer cases were identified by a linkage to the Cancer Registry of Norway via the personal identification number given to all Norwegians alive in 1960 or later. The Cancer Registry of Norway, which was initiated in 1953 (19) , is regarded as virtually complete and contains diagnoses classified by a modified version of the International Classification of Diseases, Seventh Revision, until 1993 and by the International Classification of Diseases for Oncology, Second Edition, thereafter.
All of the cases were women who had invasive breast cancer histologically confirmed between 1990 and 2007 (n = 1,132), were alive by February 2009 (n = 943), consented to be interviewed (n = 706), and had an occupational history as a nurse for at least 1 year (n = 699). The controls, who were frequency matched to the cases by the year of diagnosis and 5-year age groups, were all cancer-free at and before the year of diagnosis of the case, were alive by February 2009 (n = 1,384), consented to an interview (n = 900), and had worked a minimum of 1 year as a nurse (n = 895). Because testing for ER and PR status was rarely conducted in Norway before 1996, the analyses were further restricted to those cases diagnosed during the period from 1996 through 2007 (n = 590), with the controls being selected for the corresponding period (n = 757). Of the cases diagnosed in 1996 and later, ER status was determined for 513 (87%) subjects, of whom 87% were ER+, and PR status was determined for 509 (86%), of whom 66% were PR-positive (PR+). Of the breast cancers with a known joint receptor status, 329 (65%) were ER+/PR+ tumors, 113 (22%) were ER+/PR− tumors, 9 (2%) were ER−/PR+ tumors, and 58 (11%) were ER−/PR− tumors.
Data collection
All of the participants were interviewed by telephone by professional interviewers from Statistics Norway (http://www. ssb.no/english/) who used a structured questionnaire. A pilot study was first conducted on a small group of nurses to test the validity of the questionnaire. An invitation letter was sent to all of the potential participants 6 weeks before the interview. The letter included information about the purpose of the study (to evaluate the impact of environmental factors on the risk of breast cancer), a memo on which the respondents could write down their work history as a nurse, a letter of consent on which to provide telephone numbers, and a prepaid return envelope. A follow-up letter was sentto thosenursesfrom whom we did not receive a return letter within a few weeks. Those nurses who did not respond to any of the letters were called by telephone at telephone numbers from the computerized telephone directory to suggest a time for an interview.
The interview included questions about all of the nursing jobs that the respondent held for at least 1 year, reproductive history, use of hormonal treatments, occurrence of breast cancer in a mother or sister, smoking, height and weight at age 18 years and at the year of diagnosis/reference, frequency of alcohol consumption, sleep duration, duration of work, exposure to ionizing radiation and to chemotherapy, and diurnal preference. A night shift was defined as a shift including work between 12 PM and 6 AM. The work history and other timerelated variables were recorded up to the time of diagnosis for each case and up to the selection year for controls, hereafter called the reference year for both cases and controls.
The information on the hormone receptor status of the breast cancer cases was abstracted from the pathology reports submitted to the Cancer Registry for each cancer diagnosis.
Tumors containing more than 50% positive cells are classified as receptor-positive, tumors with 10%-50% positive cells as weakly positive, and tumors with 0%-9% positive cells as negative. For the present analyses, we chose to dichotomize the information and classify all of the tumors containing a minimum of 10% positive cells as positive.
The study was approved by the Norwegian Data Inspectorate and the Regional Committee for Medical and Health Research Ethics. Informed consent was obtained from each study participant.
Assessment of night work
For each job as a nurse, information on the year of start and end, workplace (hospital, other institution, other), employment status, and work schedule (only day shifts, only night shifts, both day and night shifts) was assessed. If the job included night shifts, the nurse was also asked about the number of night shifts per month and the number of consecutive night shifts.
In a previous report from the same case-control study (12) , different exposure measures were developed on the basis of the responses to the interview questions. In the present study, we applied the metric from that study that was a priori considered to be the least hampered by recall bias: "duration of work with a minimum of 6 consecutive night shifts," which includes both the duration and intensity of night work. Although all of the participants of this study worked night shifts during the 3 years spent in nursing school, that period was not included in the work history.
variables, and t tests were used to assess the differences in the mean values for the continuous variables between the different case groups and controls. The associations between night work and breast cancer were first examined according to ER status alone and then according to PR status alone; lastly, the risk was examined according to the joint distribution of ER and PR status. The ER−/PR+ cases were excluded from the analyses because of the small number (n = 9).
Multivariate polytomous unconditional logistic regression was performed to obtain simultaneous odds ratio estimates, and the 95% confidence intervals for each steroid receptor subgroup were compared with the same control group. Wald tests were performed to assess the heterogeneity between the odds ratio estimates of the case subgroups.
The relative risks of breast cancer according to the duration of night work with ≥6 consecutive night shifts were estimated according to the categories of "never worked night shifts," "never worked ≥6 consecutive night shifts," "<5 years with ≥6 consecutive night shifts," and "≥5 years with ≥6 consecutive night shifts." Tests for the trends across these variables were conducted by fitting ordinal values corresponding to the categories of exposure in the models. Analyses also were made with a dichotomized exposure variable (ever/never worked ≥6 consecutive night shifts).
The estimates were adjusted for the matching variables (age and period of diagnosis/reference). Potential confounders were included in a multivariate polytomous logistic regression model when the χ 2 or t test showed an association with night work or when the inclusion of the variable in the analysis changed the risk estimate by ≥10%. The following variables were included in the final models: age, period of diagnosis/ reference (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) , parity (0, 1-2, or ≥3 children), a family history of breast cancer in a mother or sister (no or yes), hormonal treatment in the previous 2 years before the reference year (no or yes), and the frequency of alcohol consumption at the reference year (less than twice per week or at least twice per week). The variables were categorized into categories previously demonstrated to be associated with cancer risk in the literature or the third quartile among the controls. All of the statistical tests were based on a 2-sided probability, with a significance level of 0.05, and were performed in Stata, release 12 (StataCorp LP, College Station, Texas). Table 1 shows the distribution of the characteristics for the receptor status-defined cases and for the controls. χ 2 tests revealed that the cases were more likely than the controls to have used hormonal treatment in the previous 2 years before the reference year (ER+/PR+ and ER+/PR− tumors) and, as expected, to have a family history of breast cancer (all 3 subgroups of tumors). No significant differences were observed between the cancer subgroups for any of the variables in Table 1 (data not shown). The distribution of most of the breast cancer risk factors was similar for the cases with and without ER/PR data available.
RESULTS
In Table 2 , the ER+ cases and ER-negative (ER-) cases were compared simultaneously with the controls. A long duration (≥5 years) of night work with ≥6 consecutive night shifts was significantly associated with ER+ tumors (odds ratio (OR) = 1.8, 95% confidence interval (CI): 1.0, 3.1; P-trend = 0.06) and was nonsignificantly associated with ER− tumors (OR = 2.8, 95% CI: 0.8, 9.2). No statistically significant difference in the odds ratios was observed for the night work variable between the ER-defined cancer subgroups (P-Wald = 0.75).
A comparison of the PR-defined breast cancers with the controls (Table 3) showed a significant association between the highest exposure and PR+ tumors (OR = 2.4, 95% CI: 1.3, 4.3) and a significantly positive trend with an increasing duration of night work (P-trend = 0.01). No significant heterogeneity was found between the odds ratios of the tumor subgroups (P-Wald = 0.26). Table 4 shows the odds ratios for the ER/PR-defined breast cancers. When compared with daytime workers, the women with the highest exposure to night work had a 2.2-fold (95% CI: 1.2, 4.1) elevated risk of ER+/PR+tumors, a 0.9-fold decreased risk of ER+/PR− tumors (95% CI: 0.3, 2.6), and a 1.9-fold elevated risk of ER−/PR− tumors (95% CI: 0.5, 7.0). No significant differences in the risk factor profiles were found between the tumor subgroups (P-Wald = 0.64). Use of a dichotomized exposure variable did not reveal significant heterogeneity for ER-defined, PR-defined, or ER/PR-defined subgroups (data not shown).
The results from the analyses of postmenopausal women were similar to those in Table 4 , showing increased odds ratios Abbreviations: CI, confidence interval; ER, estrogen receptor; OR, odds ratio; +, positive; -, negative. a Odds ratio from polytomous logistic regression analyses, adjusted for age at diagnosis (5-year age groups), period of diagnosis (before 2000 vs. 2000 and after), parity (0, 1-2, or ≥3 children), family history of breast cancer in mother or sister (no or yes), hormonal treatment in the previous 2 years before diagnosis (no or premenopausal vs. yes), and frequency of alcohol consumption at the time of diagnosis (maximum of once per week vs. at least twice per week).
b P-trend was calculated by using the category number of the exposure variable as a continuous variable. c The Wald statistic P value indicates the statistical significance of differences in odds ratios for the risk factor between ER+ and ER− cases.
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Am J Epidemiol. 2013;178(1):110-117 in the women with the highest exposure to night work for ER+/PR+ tumors (OR = 2.0, 95% CI: 1.0, 3.8) and ER−/PR− tumors (OR = 2.0, 95% CI: 0.5, 85) (data not shown). No significant odds ratio heterogeneity was found for the night work variable between the tumor subgroups when 4 exposure categories were used. However, when the dichotomized exposure variable was applied, a borderline-significant heterogeneity of odds ratios was found between the PR+ and PR− tumors (P-Wald = 0.05, data not shown). Among the premenopausal nurses, no significant association was observed between night work and breast cancer risk for any cancer subgroup, but very few had ever worked ≥6 consecutive night shifts (3 cases with ER− tumors and 4 cases with PR− tumors).
DISCUSSION
The present study shows statistically significant associations between a long duration of night work with many consecutive night shifts and increased risk of breast cancer. The strongest risks were observed for PR+ tumors, and significant trends were limited to the subgroups including PR+ tumors.
An increasing risk with an increasing duration and intensity of night work is consistent with the results found for all cancers combined in a previous study of nurses from this cohort. Similarly, in a recent study of breast cancer risk among women in the Danish military, the highest risks were associated with the longest duration in work schedules with many (≥3) night shifts per week (14) . However, the observed association between night work and PR+ tumors is a novel finding of the present study.
Breast cancer is linked to prolonged exposure to estrogens (20) . Originally, the hypothesis of a correlation between night work and breast cancer was based on the associations between shift work and exposure to light at night and reduced melatonin levels, between reduced melatonin and increased sex hormone levels, and between increased sex hormone levels and increased breast cancer risk (21, 22) . During the previous 25 years, several plausible biological mechanisms have been postulated, including the effects on a disruption of the circadian rhythm controlled by clock genes, sleep deprivation, lifestyle disturbances, and decreased vitamin D levels due to less sun exposure (23) . The association of night work with hormone receptor-defined breast cancer is, however, poorly investigated, and the results from the present study provide some clues into the biological mechanisms.
In a previous report based on data from the Nurses' Health Study, Schernhammer et al. (3) mentioned a finding of an increased risk of ER+ but not ER-breast cancer with longer durations of rotating night shifts, particularly for premenopausal women. To our knowledge, no other epidemiologic studies published to date have examined the association of night work with the risk of hormone receptor-defined breast Abbreviations: CI, confidence interval; OR, odds ratio; PR, progesterone receptor; +, positive; -, negative. a Odds ratio from polytomous logistic regression analyses, adjusted for age at diagnosis (5-year age groups), period of diagnosis (before 2000 vs. 2000 and after), parity (0, 1-2, or ≥3 children), family history of breast cancer in mother or sister (no or yes), hormonal treatment in the previous 2 years before diagnosis (no or premenopausal vs. yes), and frequency of alcohol consumption at the time of diagnosis (maximum of once per week vs. at least twice per week).
b P-trend was calculated by using the category number of the exposure variable as a continuous variable. c The Wald statistic P value indicates the statistical significance of differences in odds ratios for the risk factor between PR+ and PR− cases.
cancer. In contrast to the findings of Schernhammer et al. (3) , ER status in the present study did not have a clear effect, and an increase in risk was observed in postmenopausal women.
Interestingly, the strongest association in the present study was observed in the subgroup of PR+ cancers, which is a novel finding and suggests that progesterone could play an important role in the detrimental effects of night work. Wald tests did not show heterogeneity across the cancer subtypes, which could result from the small number of cases in some of the subgroups and, consequently, insufficient power to detect differences. When a dichotomized exposure variable was applied, however, borderline heterogeneity between PR+ and PR− tumors was observed in postmenopausal women-an interesting finding that needs replication in a larger sample.
Progesterone is an ovarian steroid hormone that is essential for normal breast development during puberty and breastfeeding. Progesterone primarily acts through its receptors, PR-A and PR-B, transcription factors that could affect the expression of multiple genes encoding the growth factors that regulate cell growth in breast tissue (24) . Although the role of PR receptors in breast cancer development and progression has not been investigated fully and remains controversial, there are animal, human, and in vitro studies that support a role for progesterone in breast cancer. For example, PR is required for mammary carcinogenesis in mice (25) . In humans, removal of the ovaries reduces the breast cancer risk by more than 50% (26, 27) . In addition, women exposed to progestincontaining hormone replacement therapy have an increased breast cancer risk compared with women taking estrogen alone or no hormone replacement therapy at all (28, 29) .
Mechanistic studies using breast epithelial cells have shown that exposure to progesterone increased expression levels of the proliferative genes cyclin D1, c-myc, p21, and p27 (30) a Odds ratio from polytomous logistic regression analyses, adjusted for age at diagnosis (5-year age groups), period of diagnosis (before 2000 vs. 2000 and after), parity (0, 1-2, or ≥3 children), family history of breast cancer in mother or sister (no or yes), hormonal treatment in the previous 2 years before diagnosis (no or premenopausal vs. yes), and frequency of alcohol consumption at the time of diagnosis (maximum of once per week vs. at least twice per week).
b P-trend was calculated by using the category number of the exposure variable as a continuous variable. c The Wald statistic P value indicates the statistical significance of differences in odds ratios for the exposure variable among the 3 case groups.
Night Work and Hormone Receptor-defined Breast Cancer 115 Am J Epidemiol. 2013;178(1):110-117 and decreased expression of the tumor suppressor gene TP53 (31) .
In relation to shift work, Langley et al. (32) recently found an increase in the levels of ER/PR hormones in shift workers. However, no clear conclusion about an association could be drawn.
The strengths of the present study include a well-defined cohort of nurses, educated during a period of more than 60 years, with relatively similar shift systems and high response rates among both cases and controls. Indeed, the selection of cases and controls from a homogenous group of women minimizes the risk of selection bias. Further strengths of this study include the use of a more accurate measure of exposure than in previous studies, including both the duration and intensity of the night work. Although the data in this study are based on subjective reporting, we consider the information on the consecutive night shifts to be fairly robust. Before 1960 in Norway, nurses' work schedules could include as many as 14 subsequent night shifts, in addition to day and evening shifts. In contrast, the maximum number of consecutive night shifts today is 3-4, a reduction that is apparent in the present data: Only 3% of the premenopausal nurses had ever worked ≥6 consecutive night shifts, versus 11% among the postmenopausal nurses. We assume that a nurse remembers whether the various jobs she had involved night shifts. Because of the stress that many night shifts must have caused and the substantial reduction of consecutive night shifts in more recent years, it is also assumed that a nurse can recall the number of consecutive night shifts worked in each job.
Some limitations of this study should also be noted. Because only nursing jobs were considered, the exposure might be underestimated if the women had also worked night shifts in other jobs. Of 189 deceased breast cancer cases who were excluded from the study, breast cancer was the cause of death for 115. Several studies assessing the association between receptor status and death from breast cancer (33) (34) (35) show somewhat higher survival rates for subjects with ER+ and PR+ tumors. If there were a significant difference in survival rates between the groups, we would expect to see an unequal distribution of the receptor status with respect to the reference period, but no such difference was observed.
Except for the cancer data, all of the information for the present study was obtained through an interview that often occurred a long time after the exposure, resulting in possible imprecision in the exposure metrics. We tried to minimize recall bias, which could result from increased public concern about night work and breast cancer risk, by presenting the study as one of the associations between different environmental factors and breast cancer. It is not probable that hormone receptor status is biased according to night work; therefore, we believe that any exposure misclassification in the present study would be nondifferential. Cases with unknown receptor status were excluded from the analyses. The risk factor profiles were generally similar between the nurses with and without available information on hormone receptor status, and there was no indication of outcomedependent selection. For some subgroups, the estimates of association did not reach statistical significance because of the low number of subjects and limited statistical power.
In summary, the results from these analyses show significantly increased risks of breast cancer from a long duration of night work with many consecutive night shifts. The strongest association was observed for PR+ cancers, which is a novel finding of this study. A significantly positive trend was found only in the subgroups that included PR+ cases. The observed lack of statistical heterogeneity between the receptor-defined subgroups of breast tumors was probably due to the small number of subjects in certain cancer subgroups. When the exposure variable was dichotomized, a borderline-significant heterogeneity was observed between PR+ and PR− tumors among postmenopausal women. Our results suggest that progesterone could play an important role in the detrimental effects of night work.
